Trial Profile
Pivotal phase III trial of SUBLIVAC(Rm) FIX Phleum pratense for allergic rhinitis/rhinoconjunctivitis.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2013
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- 05 Jan 2013 New trial record.